Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2020-02-05, Stock:ABBV, The news for the past five days is as follows:
2020-01-29: NEWS1: Joel Greenblatt: Is There Still an Edge to Be Found in the Market?.NEWS2: Form 8.3 - ABBVIE INC.
2020-01-30: NEWS1: J&J (JNJ) Plans to Develop Vaccine for New Coronavirus.NEWS2: Coronavirus update: US records first human-to-human transmission as WHO declares global emergency.NEWS3: Biogen (BIIB) Surpasses Q4 Earnings and Sales Estimates.NEWS4: Form 8.3 - Abbvie Plc - Amendment.NEWS5: Form 8.3 - ABBVIE INC - Amendment.NEWS6: FORM 8.3 - ABBVIE PLC.NEWS7: Slapping Around Martin Shkreli Won’t Cut Drug Prices.
2020-01-31: NEWS1: Lilly's Olumiant Succeeds in Another Late-Stage Eczema Study.NEWS2: Form 8.3 - Abbvie Plc.NEWS3: Amgen (AMGN) Stock Down Despite Q4 Earnings & Revenue Beat.NEWS4: Decisions, Decisions: AbbVie or Bristol-Myers Squibb?.NEWS5: AbbVie Receives Positive CHMP Opinion for MAVIRET® (glecaprevir/pibrentasvir) to Shorten Treatment Duration to Eight Weeks in Genotype 3, Treatment-Naïve Patients with Chronic Hepatitis C and Compensated Cirrhosis.NEWS6: AbbVie Receives Positive CHMP Opinion for VENCLYXTO® as a Chemotherapy-Free Combination Regimen for Patients with Previously Untreated Chronic Lymphocytic Leukemia.
2020-02-03: NEWS1: AbbVie (ABBV) Outpaces Stock Market Gains: What You Should Know.NEWS2: CDC Readies for Pandemic; Long Vaccine Timeline: Virus Update.NEWS3: Vaxart (VXRT) to Make Vaccines to Check Coronavirus, Stock Up.NEWS4: VVUS: ZenPep Deal Demonstrates PERT Interest.NEWS5: AZRX: EPI Treatment in the News.NEWS6: AZRX: EPI Treatment in the News.NEWS7: Stocks - Apple Falls in Premarket;  Drug Reports Lift Gilead, AbbVie.
2020-02-04: NEWS1: Merck's Keytruda: How Long Can It Fend Off Cancer-Treatment Rivals?.NEWS2: Merck's Keytruda: How Long Can It Fend Off Cancer-Treatment Rivals?.NEWS3: FORM 8.3 - ABBVIE PLC - AMENDMENT.NEWS4: AbbVie (ABBV) to Report Q4 Earnings: What's in the Cards?.NEWS5: FORM 8.3 - ABBVIE INC.

Answer: Rise